Global Cell & Gene Therapy Bioanalytical Testing Services Market Size & Outlook

The cell & gene therapy bioanalytical testing services industry worldwide is expected to reach a projected revenue of US$ 828.9 million by 2030. A compound annual growth rate of 7.3% is expected of the worldwide cell & gene therapy bioanalytical testing services industry from 2024 to 2030.
Revenue, 2023 (US$M)
$506.1
Forecast, 2030 (US$M)
$828.9
CAGR, 2024 - 2030
7.3%
Report Coverage
Worldwide

Global cell & gene therapy bioanalytical testing services market, 2018-2030 (US$M)

Related Markets

Global cell & gene therapy bioanalytical testing services market highlights

  • The global cell & gene therapy bioanalytical testing services market generated a revenue of USD 506.1 million in 2023 and is expected to reach USD 828.9 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 7.3% by 2030.
  • In terms of segment, bioavailability & bioequivalence studies accounted for a revenue of USD 179.0 million in 2023.
  • Bioavailability & Bioequivalence Studies is the most lucrative test type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 506.1 million
Market revenue in 2030USD 828.9 million
Growth rate7.3% (CAGR from 2023 to 2030)
Largest segmentBioavailability & bioequivalence studies
Fastest growing segmentBioavailability & Bioequivalence Studies
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test type

Other key industry trends

  • In terms of revenue, the North America accounted for 40.4% of the global cell & gene therapy bioanalytical testing services market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Kuwait is the fastest growing regional market and is projected to reach USD 1.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell & Gene Therapy Bioanalytical Testing Services Market Scope

Cell & gene therapy bioanalytical testing services market segmentation & scope
Bioavailability & Bioequivalence Studies
Pharmacokinetics
Pharmacodynamics
Other test type
Ex-vivo
In-vivo
CAR T-cell therapies
CAR-NK cell therapy
TCR-T cell therapy
Other
Cell Therapy
Gene Therapy
Gene-Modified Cell Therapy
Cell Therapy
Gene Therapy
Gene-Modified Cell Therapy
Cell Therapy
Oncology
Infectious Diseases
Neurological disorders
Rare Diseases
Others

Cell & Gene Therapy Bioanalytical Testing Services Market Companies

Name Profile # Employees HQ Website

Global cell & gene therapy bioanalytical testing services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy bioanalytical testing services market will help companies and investors design strategic landscapes.


Bioavailability & bioequivalence studies was the largest segment with a revenue share of 35.37% in 2023. Horizon Databook has segmented the Global cell & gene therapy bioanalytical testing services market based on bioavailability & bioequivalence studies, pharmacokinetics, pharmacodynamics, other test type covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Cell & Gene Therapy Bioanalytical Testing Services Test Type Outlook (Revenue, USD million, 2018-2030)
    • Bioavailability & Bioequivalence Studies
    • Pharmacokinetics
    • Pharmacodynamics
    • Other test type
  • Global Cell & Gene Therapy Bioanalytical Testing Services Product Outlook (Revenue, USD million, 2018-2030)
    • Gene Therapy
      • Ex-vivo
      • In-vivo
    • Gene-Modified Cell Therapy
      • CAR T-cell therapies
      • CAR-NK cell therapy
      • TCR-T cell therapy
      • Other
    • Cell Therapy
  • Global Cell & Gene Therapy Bioanalytical Testing Services Stage of Development Outlook (Revenue, USD million, 2018-2030)
    • Non-Clinical
      • Gene Therapy
      • Gene-Modified Cell Therapy
      • Cell Therapy
    • Clinical
      • Gene Therapy
      • Gene-Modified Cell Therapy
      • Cell Therapy
  • Global Cell & Gene Therapy Bioanalytical Testing Services Indication Outlook (Revenue, USD million, 2018-2030)
    • Oncology
    • Infectious Diseases
    • Neurological disorders
    • Rare Diseases
    • Others

Reasons to subscribe to Global cell & gene therapy bioanalytical testing services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global cell & gene therapy bioanalytical testing services market databook

  • Our clientele includes a mix of cell & gene therapy bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global cell & gene therapy bioanalytical testing services market , including forecasts for subscribers. This global databook contains high-level insights into Global cell & gene therapy bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global cell & gene therapy bioanalytical testing services market size, by regions, 2018-2030 (US$M)

Top 10 countries: Cell & gene therapy bioanalytical testing services market size, 2023 (US$M)

Global cell & gene therapy bioanalytical testing services market share, by test type, 2023 & 2030 (%, US$M)

Cell & gene therapy bioanalytical testing services market: Opportunity assessment by country

Global cell & gene therapy bioanalytical testing services market, by region, 2023 (US$M)

Global cell & gene therapy bioanalytical testing services market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more